WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012099836) TREATMENT OF COGNITIVE DYSFUNCTION IN SCHIZOPHRENIA
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/099836    International Application No.:    PCT/US2012/021472
Publication Date: 26.07.2012 International Filing Date: 17.01.2012
IPC:
A61K 31/443 (2006.01), A61P 25/18 (2006.01), A61P 25/28 (2006.01)
Applicants: TARGACEPT, INC. [US/US]; 200 East First Street, Suite 300 Winston-Salem, North Carolina 27101-4165 (US) (For All Designated States Except US).
BENCHERIF, Merouane [US/US]; (US) (For US Only).
DUNBAR, Geoffrey Charles [US/US]; (US) (For US Only).
HOSFORD, David A. [US/US]; (US) (For US Only).
GATTO, Gregory J. [US/US]; (US) (For US Only).
HAUSER, Terry [US/US]; (US) (For US Only).
JORDAN, Kristen G. [US/US]; (US) (For US Only).
SEGRETI, Anthony Carl [US/US]; (US) (For US Only)
Inventors: BENCHERIF, Merouane; (US).
DUNBAR, Geoffrey Charles; (US).
HOSFORD, David A.; (US).
GATTO, Gregory J.; (US).
HAUSER, Terry; (US).
JORDAN, Kristen G.; (US).
SEGRETI, Anthony Carl; (US)
Agent: FIX, Amy H.; Attn: Patent Docketing P.O. Box 7037 Atlanta, Georgia 30357 (US)
Priority Data:
61/433,795 18.01.2011 US
61/438,872 02.02.2011 US
61/467,278 24.03.2011 US
Title (EN) TREATMENT OF COGNITIVE DYSFUNCTION IN SCHIZOPHRENIA
(FR) TRAITEMENT D'UN DYSFONCTIONNEMENT COGNITIF EN CAS DE SCHIZOPHRÉNIE
Abstract: front page image
(EN)The present invention relates to (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide or a pharmaceutically acceptable salt thereof, pharmaceutical compositions, and methods for treating schizophrenia.
(FR)La présente invention concerne le (2S,3R)-N-(2-((3-pyridinyl)méthyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide ou un sel pharmaceutiquement acceptable de celui-ci, des compositions pharmaceutiques et des méthodes pour le traitement de la schizophrénie.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)